Vasoactive-inotropic score: evolution, clinical utility, and pitfalls

A Belletti, CC Lerose, A Zangrillo, G Landoni - Journal of cardiothoracic and …, 2021 - Elsevier
Inotropes and vasopressors frequently are administered in critically ill and perioperative
patients. However, clinical practice is highly variable across clinicians and institutions. The …

Vasoplegic syndrome following cardiothoracic surgery—review of pathophysiology and update of treatment options

LW Busse, N Barker, C Petersen - Critical Care, 2020 - Springer
Vasoplegic syndrome is a common occurrence following cardiothoracic surgery and is
characterized as a high-output shock state with poor systemic vascular resistance. The …

Vasoplegic syndrome after cardiovascular surgery: a review of pathophysiology and outcome‐oriented therapeutic management

V Datt, R Wadhhwa, V Sharma, S Virmani… - Journal of cardiac …, 2021 - Wiley Online Library
Background: Vasoplegic syndrome (VPS) is defined as systemic hypotension due to
profound vasodilatation and loss of systemic vascular resistance (SVR), despite normal or …

Vasoplegic syndrome after cardiopulmonary bypass in cardiovascular surgery: Pathophysiology and management in critical care

Z Ltaief, N Ben-Hamouda, V Rancati, Z Gunga… - Journal of Clinical …, 2022 - mdpi.com
Vasoplegic syndrome (VS) is a common complication following cardiovascular surgery with
cardiopulmonary bypass (CPB), and its incidence varies from 5 to 44%. It is defined as a …

[HTML][HTML] Treatment with angiotensin II is associated with rapid blood pressure response and vasopressor sparing in patients with vasoplegia after cardiac surgery: a …

A Klijian, AK Khanna, VS Reddy, B Friedman… - … of Cardiothoracic and …, 2021 - Elsevier
Objective: The present study investigated outcomes in patients with vasoplegia after cardiac
surgery treated with angiotensin II plus standard-of-care vasopressors. Vasoplegia is a …

What's new in cardiopulmonary bypass

EA Hessel II - Journal of cardiothoracic and vascular anesthesia, 2019 - Elsevier
This is a narrative review of recent articles (mainly published in 2017 and 2018) related to
the conduct of cardiopulmonary bypass (CPB) that should be of interest to the cardiac …

Vasopressor therapy in cardiac surgery—an experts' consensus statement

F Guarracino, M Habicher, S Treskatsch… - … of Cardiothoracic and …, 2021 - Elsevier
Hemodynamic conditions with reduced systemic vascular resistance commonly are
observed in patients undergoing cardiac surgery and may range from moderate reductions …

Continuous heart volume monitoring by fully implantable soft strain sensor

SA Dual, B Llerena Zambrano… - Advanced …, 2020 - Wiley Online Library
Cardiothoracic open‐heart surgery has revolutionized the treatment of cardiovascular
disease, the leading cause of death worldwide. After the surgery, hemodynamic and volume …

Hydroxocobalamin for the treatment of vasoplegia: a review of current literature and considerations for use

AD Shapeton, F Mahmood… - Journal of Cardiothoracic …, 2019 - jcvaonline.com
VASOPLEGIA is a term used to describe hypotension in the setting of high pressor
requirements and normal or increased cardiac output. A commonly used numerical …

Vasoplegia after cardiopulmonary bypass: A narrative review of pathophysiology and emerging targeted therapies

TJ Barnes, MA Hockstein… - SAGE open medicine, 2020 - journals.sagepub.com
Cardiovascular disease remains the leading cause of death in the United States, and
cardiopulmonary bypass is a cornerstone in the surgical management of many related …